Company Description
Pasqal Holding SA develops neutral-atom quantum computers and provides a full-stack quantum computing platform.
The company designs and manufactures quantum processors based on neutral-atom technology and integrates them with high-performance computing environments for hybrid quantum computing applications.
Its platform includes quantum hardware, programming, and simulation tools, such as Pulser and Pulser Studio; and cloud-based access that enables users to develop, test, and run quantum algorithms remotely.
The company also develops quantum software tools, developer SDKs, emulation capabilities, and cloud services through its Pasqal compute platform to support quantum application development.
In addition, it provides consulting, training, and collaborative development of quantum algorithms and applications for various industries, including finance, energy, healthcare, and logistics.
Pasqal Holding SA is based in Palaiseau, France.
| Country | France |
| Founded | 2019 |
| Industry | Computer Hardware |
| Sector | Technology |
| Employees | 275 |
| CEO | Wasiq Bokhari |
Contact Details
Address: 24 Av. Emile Baudot Palaiseau, 91120 France | |
| Phone | 33 6 69 75 92 53 |
| Website | pasqal.com |
Stock Details
| Ticker Symbol | PSQL |
| Exchange | NASDAQ |
| Reporting Currency | EUR |
| CIK Code | 2119292 |
| ISIN Number | FR0014019QW4 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Dr. Wasiq Bokhari Ph.D. | Chief Executive Officer and Executive Chairman |
| Georges-Olivier Reymond | Co-Founder, Chief Strategic Alliances Officer and Director |
| Alain Aspect | Co-Founder, and Chair of Scientific Advisory Board |
| Prof. Antoine Browaeys | Co-founder, Chief Scientific Officer, Member of Scientific Advisory Board and Director |
| Stephane Rougeot | Chief Financial Officer |
| Barbara Bonneau | Chief Operating Officer |
| Dr. Loic Henriet | Chief Technology Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 7, 2026 | SCHEDULE 13G | Filing |
| Oct 7, 2026 | SCHEDULE 13G | Filing |
| Oct 7, 2026 | 424B3 | Prospectus |
| Oct 6, 2026 | EFFECT | Notice of Effectiveness |
| Oct 2, 2026 | POS AM | Post-Effective amendments for registration statement |
| Sep 28, 2026 | 424B3 | Prospectus |
| Sep 28, 2026 | 6-K | Report of foreign issuer |
| Sep 24, 2026 | 424B3 | Prospectus |
| Sep 24, 2026 | 6-K | Report of foreign issuer |
| Sep 18, 2026 | EFFECT | Notice of Effectiveness |